Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Morita E et al. Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils. 1990 Scand. J. Immunol. pmid:2125361
van der Poll T et al. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6. 1996 Scand. J. Immunol. pmid:8560191
O'Donnell MC and Fiedel BA Histamine secretion from human leucocytes stimulated by basophil-derived platelet-activating factor. 1981 Scand. J. Immunol. pmid:6171870
Morita E et al. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. 1989 Scand. J. Immunol. pmid:2544988
Renkonen R et al. Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factor. 1989 Scand. J. Immunol. pmid:2602912
Hilliquin P et al. Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids. 1995 Scand. J. Rheumatol. pmid:7777830
Dulioust A et al. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. 1992 Scand. J. Rheumatol. pmid:1529281
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Schaller MD [Sepsis syndrome: progress and therapeutic perspectives]. 1992 Schweiz Med Wochenschr pmid:1604283
Ding Z et al. Inhibitory effects of isoproterenol on PAF-induced endothelial cell permeability and morphological changes. 1996 Sci. China, C, Life Sci. pmid:8760474
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Voelkel NF et al. Nonimmunological production of leukotrienes induced by platelet-activating factor. 1982 Science pmid:7123233
Thurston G et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. 1999 Science pmid:10617467
Kornecki E and Ehrlich YH Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. 1988 Science pmid:3381103
Abisogun AO et al. The involvement of platelet activating factor in ovulation. 1989 Science pmid:2911750
Darius H et al. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. 1986 Science pmid:3082008
Kornecki E et al. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. 1984 Science pmid:6150550
Teruel MN and Meyer T Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. 2002 Science pmid:11884760
Wang R et al. [High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)]. 1999 Se Pu pmid:12552702
Igarashi Y [Physiology of sphingosine 1-phosphate: regulation of cell motility and platelet function]. 1997 Seikagaku pmid:9431007
Sato A and Ebina K [Interaction between Asp-hemolysin-related synthetic peptides and oxidized LDL/lysophospholipids]. 2013 Seikagaku pmid:23819394
Tokumura A and Tsukatani H [Antagonists of platelet activating factor]. 1985 Seikagaku pmid:3009656
Shindou H [Lysophospholipid acyltransferase and platelet-activating factor (PAF) biosynthetic enzyme]. 2008 Seikagaku pmid:18341030
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Satouchi K [Platelet activating factor (PAF)--a new chemical mediator of inflammation]. 1983 Seikagaku pmid:6350499
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Moschos MM et al. In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism. 2017 Semin Ophthalmol pmid:26270771
Felsen D et al. Inflammatory mediators and interstitial cystitis. 1991 Semin Urol pmid:1853005
Moore TL and Weiss TD Mediators of inflammation. 1985 Semin. Arthritis Rheum. pmid:3936177
Lorant DE et al. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. 1995 Semin. Cell Biol. pmid:8562922
Murer EH The role of platelet calcium. 1985 Semin. Hematol. pmid:3901271
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Barnes JL and Venkatachalam MA The role of platelets and polycationic mediators in glomerular vascular injury. 1985 Semin. Nephrol. pmid:2957770
Fischereder M et al. Therapeutic strategies in the prevention of acute renal failure. 1994 Semin. Nephrol. pmid:8140341
Caplan MS et al. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. 2005 Semin. Pediatr. Surg. pmid:16084401
Frost BL and Caplan MS Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics. 2013 Semin. Pediatr. Surg. pmid:23611612
Frost BL et al. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. 2008 Semin. Perinatol. pmid:18346533
Roudebush WE Seminal platelet-activating factor. 2007 Semin. Thromb. Hemost. pmid:17253192
Carveth HJ et al. Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin. 1992 Semin. Thromb. Hemost. pmid:1315452
Whatley RE et al. Production of platelet-activating factor by endothelial cells. 1987 Semin. Thromb. Hemost. pmid:3321437
Silvestro L et al. Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. 1994 Semin. Thromb. Hemost. pmid:7527938
Braquet P et al. Effect of platelet-activating factor on platelets and vascular endothelium. 1989 Semin. Thromb. Hemost. pmid:2546255
Fu JM [Effects of platelet activating factor on blood platelets]. 1989 Sheng Li Ke Xue Jin Zhan pmid:2549618
Yu SQ [Effects of platelet-activating factor (PAF) and its antagonists on the male reproduction]. 1995 Sheng Li Ke Xue Jin Zhan pmid:7604226
Yin M and Fang ZY [Platelet-activating factor]. 1989 Sheng Li Ke Xue Jin Zhan pmid:2692167
Liu Y and Kang GF [Lipid mediators and liver injury]. 1995 Sheng Li Ke Xue Jin Zhan pmid:8745570
Wu QX [Amplification and desensitization in platelet activation]. 1992 Sheng Li Ke Xue Jin Zhan pmid:1299958
Zeng NX [Platelet activating factor and gastrointestinal mucosa injuries]. 1991 Sheng Li Ke Xue Jin Zhan pmid:1947987
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Hu GL and Guo HS [Progress in platelet-activating factor receptor research]. 1997 Sheng Li Ke Xue Jin Zhan pmid:10921090